MENU
+Compare
SMMT
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$36.68
Change
+$3.45 (+10.38%)
Capitalization
27.07B

SMMT Summit Therapeutics Forecast, Technical & Fundamental Analysis

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases... Show more

Industry: #Biotechnology
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SMMT with price predictions
Apr 23, 2025

Momentum Indicator for SMMT turns positive, indicating new upward trend

SMMT saw its Momentum Indicator move above the 0 level on April 11, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 103 similar instances where the indicator turned positive. In of the 103 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SMMT just turned positive on April 11, 2025. Looking at past instances where SMMT's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

SMMT moved above its 50-day moving average on April 10, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SMMT crossed bullishly above the 50-day moving average on April 15, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +3 3-day Advance, the price is estimated to grow further. Considering data from situations where SMMT advanced for three days, in of 273 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SMMT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SMMT broke above its upper Bollinger Band on April 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SMMT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (69.444) is normal, around the industry mean (14.056). P/E Ratio (26.355) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.992).

View a ticker or compare two or three
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SMMT is expected to report earnings to rise 34.86% to -9 cents per share on May 08

Summit Therapeutics SMMT Stock Earnings Reports
Q1'25
Est.
$-0.09
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.03
Q1'24
Beat
by $0.01
The last earnings report on February 24 showed earnings per share of -7 cents, beating the estimate of -7 cents. With 7.59M shares outstanding, the current market capitalization sits at 27.07B.
A.I. Advisor
published General Information

General Information

a developer of novel medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
601 Brickell Key Drive
Phone
+1 650 460-8308
Employees
105
Web
https://www.smmttx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SVM3.760.15
+4.16%
Silvercorp Metals
ATAT24.340.52
+2.18%
Atour Lifestyle Holdings Limited
WINT1.110.02
+1.83%
Windtree Therapeutics Inc.
ZTEK1.150.01
+0.88%
Zentek Ltd
CNA48.280.19
+0.40%
CNA Financial Corp

SMMT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SMMT has been closely correlated with BCDA. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SMMT jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMT
1D Price
Change %
SMMT100%
+21.50%
BCDA - SMMT
70%
Closely correlated
+5.57%
VBIZF - SMMT
42%
Loosely correlated
N/A
XERS - SMMT
35%
Loosely correlated
+0.73%
BNTX - SMMT
34%
Loosely correlated
+9.70%
XNCR - SMMT
32%
Poorly correlated
+2.07%
More

Groups containing SMMT

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMT
1D Price
Change %
SMMT100%
+21.50%
SMMT
(2 stocks)
93%
Closely correlated
+4.03%